Austin Awarded State of The Art Biopharmaceuticals Facility

The Austin Company have been appointed by Porton Biopharma Ltd to undertake the detailed design and construction of a new, state of the art Biopharmaceutical facility, following a competitive tender process, judged on both commercial and technical submission.

In a “ground breaking ceremony” on 17th June 2016 led by Baroness Scott of Bybrook OBE, Porton Biopharma Ltd (PBL) has begun the construction of a new pharmaceutical development facility which will provide state-of–the–art facilities for its teams of scientists.

The circa 530m² single story building has been designed to reflect modern best practise in laboratory design and will replace older facilities that had been well utilised over the years.    The new facility will feature a fermentation suite with a range of bench-scale reactors and a down-stream processing suite for activities such as filtration and chromatography, all supported by preparation areas and a plant room.

The building will accommodate a team of scientists and technicians who are dedicated to developing and improving the methods used in the pharmaceutical manufacture of life saving products.

As well as improving processes and yields for PBL products, the facilities will also be used to undertake developmental contract work for PBL customers who wish to translate their research into clinical outcomes. These customers will benefit from the knowledge and experience that have developed over the years by working on licensed biopharmaceuticals.

Commenting on the start of the construction phase, Dr Trevor Marks Director of Development said “my team are really looking forward to the completion of this new state-of-the-art facility later in the year and all the new equipment that they will be available to help deliver increased benefits for customers and their future patients”.

Baroness Scott said: “We are delighted to be able to support Porton Biopharma with the important work that they do and the opportunities that this brings to Wiltshire. I look forward to returning to see the new labs when they are up and running.”

Prakash Davda of The Austin Company of UK said”We are delighted to be working with Porton Biopharma Ltd on this prestigious project and look forward to handing over this cutting edge facility to begin operation”

Austin’s multi-disciplinary in-house, design team have completed the design and are now supporting the Austin’s construction team as the build progresses. The construction phase will last for 7 months and is due to be handed over to PBL mid-December.

To read about the recent ground-breaking ceremony click here.


  • architecture
  • mechanical
  • electrical
  • structural
  • public health
  • construction
  • management